Viscardia
Manufacturing · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8770 SW Nimbus Ave Ste D, Beaverton, Ore...Phone Number
(503) 431-3820Website
www.viscardia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Viscardia
VisCardia has developed an innovative implantable device therapy aimed at treating heart failure, particularly for patients with reduced ejection fraction and preserved ventricular synchrony. The company addresses the health economic burden posed by heart failure, affecting millions and resulting in significant healthcare costs. VisCardia's minimally-invasive therapy offers an alternative to those whose only options have been complicated surgical procedures or inadequate drugs. The company's initial clinical studies have been concluded in Europe, with results expected to be presented at major cardiology scientific meetings.Explore more
Viscardia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viscardia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Viscardia has new funding data
Viscardia, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Viscardia launches new products
Check if Viscardia has recently received funding, and reach out quickly before it becomes old news!
Check out if Viscardia is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Viscardia
Earning: See what the market has to say on Viscardia recently announced quarterly report
Click to see if Viscardia had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Viscardia
Find 2 more new buyers
Compare Similar Companies to Viscardia
Compare insights from companies similar to Viscardia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Viscardia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Viscardia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Viscardia.
Viscardia financials insights
Gather financial insights about Viscardia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$9.5M
Private Equity
$40M
Viscardia Tech Stack
A closer look at the technologies used by Viscardia
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
Funding
Viscardia News & Media
VisCardia Secures $40 Million Growth Financing to Advance VisONE™ Heart Failure ...
VisCardia, Inc., a medical device company pioneering a novel cardiac-support therapy for patients with heart failure, today announced it has secured $40 millionACC.25 Panel of Experts Awards VisCardia Top Honors for Innovation in MedTech
VisCardia wins ACC.25 Innovation Pitch Competition Award PORTLAND, OR, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- VisCardia, Inc. is honored to announce that our team has won the judge’s vote during the Future Hub ACC.25 Innovation Pitch …CMS Agrees With VisCardia on the Value of Synchronized Diaphragmatic Stimulation
PORTLAND, OR, UNITED STATES, November 5, 2024 /EINPresswire.com/ -- VisCardia, Inc. announced today that they have received payment assignments for the designated CPT III codes for VisONE SDS® therapy by the Centers for Medicare and Medicaid Services ( …VisCardia Receives US FDA IDE Approval to Start the RECOVER HF Clinical Study
PORTLAND, OREGON, UNITED STATES, July 30, 2024 /EINPresswire.com/ -- VisCardia, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of an Investigational Device Exemption (IDE) to study the safety and effectiveness of the VisONE SDS …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viscardia
Sign Up For FreeTo access detailed company insights
VisCardia has developed an innovative implantable device therapy aimed at treating heart failure, particularly for patients with reduced ejection fraction and preserved ventricular synchrony. The company addresses the health economic burden posed by heart failure, affecting millions and resulting in significant healthcare costs. VisCardia's minimal... Read More
